Below are the top large-cap drug manufacturers stocks on the NYSE and the NASDAQ in terms of return on equity.
The trailing-twelve-month return on equity at Shire plc (NASDAQ: SHPG) is 50.50%. Shire's PEG ratio is 1.01.
The Supreme Court will examine Oklahoma’s lethal-injection protocol, bringing new scrutiny to drug formulas that states have adopted as foreign drug manufacturers have refused to provide narcotics for U.S. executions.
By Joseph Cafariello:
* Note to reader: All data is as of the close of Friday, October 3, 2014, and is still very much relevant for the purpose of the comparison, producing precisely the same results.
The Major Drug Manufacturers industry in...
(MedPage Today) -- As federal regulators have been drawing up new rules for the 340B drug discount program, a pitched battle has broken out between hospitals and drug manufacturers who say the program is now bloated and badly regulated.
REUTERS - spate of regulatory warnings for India's generic drug manufacturers will add a new emphasis on the quality of such medicines in an industry long dominated by the ability to deliver treatments as cheaply as possible, analysts say.
By S.Z. Berg
NEW YORK (MainStreet)--The Food and Drug Administration (FDA) announced a proposal to revise drug labeling regulations for generic drugs to create parity among brand name and generic drug manufacturers. The revised rule would allow...
Oops! Unable to complete your request. Please refresh your browser.